Meet Kirsty Smitten, passionate about antimicrobial resistance and microbiology!
Kirsty Smitten is a PhD student at The University of Sheffield, developing ruthenium antimicrobial compounds to treat multi-drug resistant bacteria. She is passionate about this field because AMR already causes 700,000 deaths per year and by 2050 this figure is expected to rise to 10 million. Kirsty wants to use her compounds to reduce these predicted deaths caused by AMR.